|
|
Affymax, Takeda announce US FDA acceptance of NDA for peginesatide - pharmabiz.com |
pharmabiz.com
If approved, peginesatide will be the first once-monthly Erythropoiesis Stimulating Agent (ESA) available for the treatment of anaemia associated with CKD patients on dialysis in the United States. Peginesatide is a synthetic, PEGylated peptidic
|
|
|
Impact of sleep position on stone clearance after shock wave lithotripsy in ... - UroToday |
UroToday
We evaluated the impact of sleep position on the effectiveness of shock wave lithotripsy (SWL) in renal calculi. Patients (n = 120) with a single radiopaque renal stone who were candidates for SWL were enrolled. For studying patients' position during
|
|
Simple Urine Test Detects Silent Kidney Disease - Newswise (press release) |
Newswise (press release)
The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice.
|
|
Best Post-Transplant Drug Regimen Identified for People with New Kidneys - Newswise (press release) |
Newswise (press release)
The study, conducted by Giselle Guerra, MD, and colleagues at the University of Miami, appears in an upcoming issue of the Journal of the American Society Nephrology (JASN), a publication of the American Society of Nephrology.
|
|
Local dialysis clinic part of chain being sued - Eagle Tribune |
Eagle Tribune
By Doug Ireland
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
LONDONDERRY — The parent firm of a local kidney dialysis provider is being sued by whistleblowers who claim the company threw away medicine as part of a Medicare fraud scam. DaVita Derry of Action Boulevard in
|
|
|
|
|
<< Start < Prev 771 772 773 774 775 776 777 778 779 780 Next > End >>
|
|
Page 777 of 2630 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
